首页 | 本学科首页   官方微博 | 高级检索  
检索        

人工髋关节置换肝硬化患者围置换期的处理
引用本文:许杰,黄晶,马若凡,李登,蔡志清,李亮平.人工髋关节置换肝硬化患者围置换期的处理[J].中国临床康复,2013(52):8967-8973.
作者姓名:许杰  黄晶  马若凡  李登  蔡志清  李亮平
作者单位:[1]中山大学孙逸仙纪念医院骨科,广东省广州市510120 [2]广东省医学科学院,广东省人民医院感染科,广东省广州市510080
摘    要:背景:肝硬化对行人工关节置换等骨科治疗者往往产生负面影响,其围置换期处理是骨科医生的一大挑战。目的:分析合并肝硬化患者实施人工髋关节置换的安全性、可行性。方法:回顾性分析13例合并肝硬化的人工髋关节置换患者的临床资料,总结置换前后的诊治措施及疗效。结果与结论:13例患者髋关节置换均顺利完成,随访均超过5个月。置换前Child-Pugh分级A级7例病例中5例置换后2周内动态观察评级仍维持A级,2例上升为B级,护肝支持治疗后均按时拆线出院。置换前B级者6例中2例置换后黄疸加剧并腹水,升为C级,其中1例置换后5d出现上消化道出血,予以生长抑素及质子泵抑制剂应用,出血迅速控制,患者经治疗均痊愈出院。随访时Harris评分髋关节的功能良好。结果提示在充分评估肝功能状况,全面围手术期处理的保障下,肝硬化患者行人工髋关节置换手术是安全可行的。

关 键 词:骨关节植入物  人工假体  肝硬化  围手术期  关节置换    Child-Pugh分级  肝功  白蛋白  胆红素

Peri-operative treatment for total hip replacement in patients with hepatic cirrhosis
Xu Jie,Huang Jing,Ma Ruo-fan,Li Deng,Cai Zhi-qing,Li Liang-ping.Peri-operative treatment for total hip replacement in patients with hepatic cirrhosis[J].Chinese Journal of Clinical Rehabilitation,2013(52):8967-8973.
Authors:Xu Jie  Huang Jing  Ma Ruo-fan  Li Deng  Cai Zhi-qing  Li Liang-ping
Institution:1Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China; 2Department of Infection, Guangdong Academy of Medical Sciences, Guangdong General Hospital Guangzhou 510080, Guangdong Province, China)
Abstract:BACKGROUND:Hepatic cirrhosis may adversely affect the outcome of major orthopedic surgery, such as total hip arthroplasty. Peri-operative treatment is the chal enge for al orthopedic surgeons. OBJECTIVE:To analyze the safety and feasibility of hip replacement surgeries in patients with hepatic cirrhosis. METHODS:Thirteen patients with hepatic cirrhosis that underwent hip replacement were retrospectively analyzed to evaluate the treatments and their efficacy before and after replacement. RESULTS AND CONCLUSION:Al 13 surgeries were successful y performed. Al cases were fol owed up for more than five months and were graded according to Child-Pugh Criteria for hepatic functional reserve preoperatively and postoperatively. Five cases of the seven preoperative grade A cases preserved grade A postoperatively during a two-week observation, while another two cases rose to grade B and needed hepatic conservation treatment before discharge. Two cases of the six preoperative grade B cases rose to grade C with developed jaundice and ascites. Of the two, one even suffered a complication of upper gastrointestinal hemorrhage 5 days after surgery. Somatostatin and proton pump inhibitors were administered to stop bleeding. Al cases gained a satisfying recovery. Harris hip score at fol ow-up showed favorable hip function. Hip replacement is safe and feasible for patients with hepatic cirrhosis when ful evaluation of hepatic function and appropriate perioperative management are ensured.
Keywords:hepatic cirrhosis  arthroplasty  replacement  hepatic inadequacy  albumin
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号